CheriGeistPAMPAP, PA-C, FAAPA

PubMed

• 89 citations
  Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
  Johannes Schwarzenberg, Johannes Czernin, Timothy F. Cloughesy, Benjamin M. Ellingson, Whitney B. Pope
  Clinical Cancer Research. 2014-07-01
• 54 citations
  The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer
  Arti Hurria, Sunita K. Patel, Joanne E. Mortimer, Thehang Luu, George Somlo
  Clinical Breast Cancer. 2014-04-01
• 50 citations
  Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.
  Natalie L. Rasgon, Cheri Geist, Heather A. Kenna, Tonita E. Wroolie, Katherine E. Williams
  Plos One. 2014-03-12

Books/Book Chapters

• PET in the Evaluation of Alzheimer’s Disease and Related Disorders 
  Chapter: Interpretive Practice Atlas 
  Page 151 - 210Silverman DHS, Lau V, Geist C, Siu EEditors: Silverman DHS.Springer, New York2009
• The Effects of Estrogen on Brain Function 
  Chapter: Clinical data on estrogen effects in the central nervous system 
  Page 79 - 94Silverman DHS, Geist CL, Rasgon NLEditors: Rasgon NL.The Johns Hopkins University Press, Baltimore2006

Abstracts/Posters

• Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks
  Nguyen A, Geist C, Ganz P, Kwan L, Castellon S, Irwin M, Bower J, Czernin J, Phelps M, Silverman D., ) J Nucl Med., 1/1/2012
• Longitudinal changes in regional brain metabolism associated with endocrine therapy in prospectively studied breast cancer (BC) patients
  Pomykala K, Geist C, Ganz P, Kwan L, Castellon S, Cheng I, Irwin M, Czernin J, Phelps M, and Silverman D, J Nucl Med, 1/1/2012
• Prescription pattern of Alzheimer-specific drugs is positively associated with immediate release of brain PET scan data in the Metabolic Cerebral Imaging in Incipient ...
  Chew J, Geist C, Pomykala K, Foster N, Hoffman J, Dennett K, Zamrini E, Czernin J, Phelps M, Silverman D., J Nucl Med., 1/1/2012
• Regional PET activations with trigeminal nerve stimulation (TNS) and correlation with therapeutic response
  Schrader LM, Geist CL, DeGiorgio C, Silverman D, Miller P, Susselman MK, Cook IA, Epilepsy Curr, 1/1/2012
• The association between aromatase inhibition (AI), cognitive function, and PET metabolism
  Hardt M, Silverman D, Patel S, Geist C, Somlo G, Mortimer J, Luu T, Ramani R, Katheria V, Hansen K, Brown J, Jayani R, Chuang C, Hurria A, International Cognition and Cancer Task Force, 1/1/2012
• Cerebral Function after Breast Cancer Treatment
  Pomykala K, Geist CL, Ganz P, Cheng I, Kwan L, Castellon SA, Breen EA, Bower JE, Irwin MR, Czernin J, International Cognition and Cancer Task Force., 1/1/2012
• Prescription of Alzheimer’s-specific drugs and long-term preservation of language function are positively associated with early release of regional cerebral metabolic ...
  Silverman D, Chew J, Geist C, Pomykala K, Lu P, Foster N, Hoffman J, Dennett K, Czernin J, Phelps M., Alzheimer’s and Dementia,, 1/1/2012
• Metabolic tumor volume by 18F-FDOPA PET is predictive of treatment response in patients with recurrent high-grade gliomas on anti-angiogenic therapy as early as 2 week...
  Schwarzenberg J, Cloughesy T, Czernin J, Ellingson B, Pope W, Silverman D, Geist C, Phelps M, Chen W., J Nucl Med., 1/1/2012
• Altered amino acid uptake associated with chemotherapy and radiation exposure in subjects with primary brain tumors.
  Geist C, Yu A, Chen W, Cloughesy T, Munagala N, Robertson C, Czernin J, Phelps M, Silverman D, J Nucl Med., 1/1/2011
• Metabolic tumor volume changes by amino acid PET tracer FDOPA is predictive of treatment response in patients with recurrent high-grade gliomas on bevacizumab therapy.
  Schwarzenberg J, Cloughesy T, Czernin J, Geist C, Phelps M, Chen W, Neuro-oncology, 1/1/2011
• 18F-FLT-PET uptake dynamics and overall survival predictions for patients with recurrent high-grade glioma on bevacizumab therapy
  Schwarzenberg J, Czernin J, Cloughesy T, Ellingson B, Geist C, Phelps M, Chen W, Neuro-oncology, 1/1/2011
• Regional PET Activation with Trigeminal Nerve Stimulation in Major Depression
  Cook IA, Schrader ML, Geist CL, Silverman DHS, Miller PR, Susselman MK, DeGiorgio CM, ) American Society of Clinical Psychopharmacology: New Clinical Drug Evaluation Unit., 1/1/2011
• Differential effects of estrogen preparation on changes in regional cerebral metabolism in postmenopausal women.
  Rasgon NL, Kenna HA, Wroolie T, Geist C, Epel E, Kroenke C, Lin J, Silverman D, Neuropsychopharmacology, 2011
• Regional brain metabolism and circulating inflammatory cytokines in breast cancer patients after adjuvant chemotherapy
  Silverman D, Geist C, Pomykala K, Breen E, Bower J, Kwan L, Irwin M, Czernin J, Phelps M, Ganz P, J Nucl Med, 1/1/2011
• Regional cerebral activity associated with self-perception of memory problems in brains of breast cancer patients soon after adjuvant chemotherapy
  Geist C, Pomykala K, Silverman D, Ganz P, Kwan L, Bower J, Irwin M, Czernin J, Phelps M, Castellon S., J Nucl Med., 2011
• Changes in regional brain metabolism following initial therapy for breast cancer.
  Pomyala K, Geist C, Silverman D, Kwan L, Bower J, Irwin M, Czernin J, Phelps M, Ganz P., J Nucl Med., 1/1/2011
• . Effects of trigeminal nerve stimulation on regional brain activity in depression
  Silverman D, Geist C, Cook I, DeGiorgio C, Miller P, Susselman M, Schrader L, J Nucl Med, 1/1/2011
• 18F-FLT-PET uptake dynamics and overall survival predictions for patients with recurrent high-grade glioma on bevacizumab therapy
  Schwarzenberg J, Czernin J, Cloughesy T, Geist C, Silverman D, Satyamurthy N, Phelps M, Chen W, J Nucl Med., 1/1/2011
• Objective neuropsychologic performance is associated with levels of medial frontal, temporal, cerebellar activity in brains of breast cancer patients soon after adjuva...
  Geist C, Pomykala K, Silverman D, Ganz P, Kwan L, Bower J, Czernin J, Phelps M, Castellon S., J Nucl Med., 1/1/2011
• Regional brain metabolism and peripheral cytokine levels following adjuvant chemotherapy
  21. Silverman DH, Geist CL, Yang CC, Bower JE, Lee SK, Kwan L, Castellon SA, Czernin J, Ganz P, J Nucl Med., 2010
• Prognostic value of 18F-FDOPA PET in patients with treated low-grade gliomas
  Geist C, Cloughesy T, Czernin J, Silverman DHS, Satyamurthy N, Phelps M, Lai A, Nghiemphu L, Chen W., J Nucl Med., 1/1/2010
• Relationships between neuropsychological function and brain activity following adjuvant chemotherapy
  Yang CC, Geist CL, Castellon S, Silverman DHS, Lee SK, Kwan L, Czernin J, Ganz P, J Nucl Med., 1/1/2010
• Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women
  Silverman DHS, Lee SK, Geist CL, Yang CC, Togawa K, Katheria VV, Czernin J, Phelps ME, Hurria A., J Nucl Med., 1/1/2010
• Estrogen effects on regional cerebral metabolism and neuropsychological performance in women at risk for Alzheimer’s disease
  Rasgon N, Kenna H, Geist C, Powers B, Williams KE, Wroolie T, Silverman D, Maturitas, 2009
• Sex-specific metabolic decline of temporal lobe regions in Alzheimer’s Disease (AD).
  Wong T, Geist C, Silverman DH, Alzheimer’s and Dementia, 2009
• Join now to see all